Seretis, K.; Sfaelos, K.; Boptsi, E.; Gaitanis, G.; Bassukas, I.D.
The Neutrophil-to-Lymphocyte Ratio as a Biomarker in Cutaneous Oncology: A Systematic Review of Evidence beyond Malignant Melanoma. Cancers 2024, 16, 1044.
https://doi.org/10.3390/cancers16051044
AMA Style
Seretis K, Sfaelos K, Boptsi E, Gaitanis G, Bassukas ID.
The Neutrophil-to-Lymphocyte Ratio as a Biomarker in Cutaneous Oncology: A Systematic Review of Evidence beyond Malignant Melanoma. Cancers. 2024; 16(5):1044.
https://doi.org/10.3390/cancers16051044
Chicago/Turabian Style
Seretis, Konstantinos, Konstantinos Sfaelos, Elena Boptsi, Georgios Gaitanis, and Ioannis D. Bassukas.
2024. "The Neutrophil-to-Lymphocyte Ratio as a Biomarker in Cutaneous Oncology: A Systematic Review of Evidence beyond Malignant Melanoma" Cancers 16, no. 5: 1044.
https://doi.org/10.3390/cancers16051044
APA Style
Seretis, K., Sfaelos, K., Boptsi, E., Gaitanis, G., & Bassukas, I. D.
(2024). The Neutrophil-to-Lymphocyte Ratio as a Biomarker in Cutaneous Oncology: A Systematic Review of Evidence beyond Malignant Melanoma. Cancers, 16(5), 1044.
https://doi.org/10.3390/cancers16051044